OVARIAN CANCER – PARP Inhibitors And Beyond

Date: May 8, 2021

Location: Online Webinar

On World Ovarian Cancer Day and in the midst of a global pandemic, Ireland’s foremost Ovarian Cancer Campaigners, Researchers and Patient Advocates advised women across Ireland not to ignore the warning signs of Ovarian Cancer, a disease commonly known as the ‘silent killer’.

As part the activity the public and health care professionals were invited to attend a free webinar. While there have been many advances in the diagnosis and treatment of other cancers, ovarian cancer is just entering a new era of treatment with poly ADP ribose polymerase (PARP) inhibitors being the most promising drugs that have entered the clinic. PARP inhibitors are having a significant impact as a maintenance treatment on disease free intervals and are more beneficial in patients with a BRCA mutation. Other patient cohorts may benefit also and identifying these will be important for research going forward. On world ovarian cancer day 2021 the organisers hosted a free webinar on “Ovarian cancer; PARP inhibitors and beyond” given by Dr Dearbhaile Collins.